ABH Healthcare Listing Preview: Shares List Tomorrow as QIB Demand Sharply Outpaced Retail Participation
- August 31, 2026
- Posted by: Neeraj Pandey
- Category: IPO
ABH Healthcare lists on NSE SME tomorrow, Sep 1, 2026. Subscription: QIB 8.37x, Individual 0.93x, NII 0.67x (as of Day 3 close). Allotment finalized Aug 28.
Quick Answer
ABH Healthcare shares are scheduled to list on the NSE SME platform tomorrow, September 1, 2026, after the initial public offering closed for subscription on August 27, 2026. The issue saw a wide divergence between investor categories, with qualified institutional buyers subscribing 8.37 times their reserved portion, while individual investors were subscribed 0.93 times and non-institutional investors 0.67 times.
ABH Healthcare Limited’s shares are scheduled to list on the NSE SME platform tomorrow, September 1, 2026, following the close of its Rs 34.98 crore initial public offering on August 27, 2026. The issue displayed a notable divergence between investor categories through its bidding window, with the qualified institutional buyer (QIB) category recording the strongest demand at 8.37 times, while individual investors were subscribed 0.93 times and non-institutional investors (NIIs) 0.67 times as of the close of Day 3 trading.
This pattern, where institutional confidence significantly outpaced retail and non-institutional participation, is a distinctive feature of ABH Healthcare’s subscription story compared to some of the other issues from the same primary market week.
Click Here – Get Free Investment Predictions
About ABH Healthcare
Track ABH Healthcare’s live price once it lists on the Univest Screener
ABH Healthcare Limited manufactures active pharmaceutical ingredients (APIs) and pharma intermediates from its manufacturing base in Ferozepur, Punjab. The company’s promoters include Kamal Baghi, Saurabh Baghi, and Vaishali Saini, with the business operating under the brand identity associated with the Baghi family name.
ABH Healthcare IPO: Key Details
| Parameter | Details |
|---|---|
| IPO Dates | August 24 to August 27, 2026 |
| Price Band | Rs 96 to Rs 102 per share |
| Total Issue Size | ~Rs 34.98 crore |
| QIB Subscription | 8.37x |
| Individual Investor Subscription | 0.93x |
| NII Subscription | 0.67x |
| Allotment Date | August 28, 2026 |
| Demat Credit Date | August 31, 2026 |
| Listing Date | September 1, 2026 (tomorrow) |
| Listing Platform | NSE SME |
What the Category-Wise Divergence Suggests
The wide gap between the strong QIB subscription of 8.37 times and the more measured retail and NII response, both below 1 time, reflects a subscription pattern where institutional confidence ran well ahead of individual investor participation for this specific issue. Investors evaluating ABH Healthcare should keep in mind that heavy institutional participation combined with more modest retail demand can sometimes signal that professional investors see value the broader retail market has been slower to recognise, though outcomes vary from issue to issue.
What to Expect on Listing Day
With institutional investors showing the strongest conviction in this issue, market participants will watch closely to see whether that confidence translates into a firm listing-day performance when the stock begins trading tomorrow. As with any SME listing, investors should note that these shares typically trade with lower liquidity compared to mainboard listings.
Univest does not publish grey market premium figures. Grey market premium is an unofficial and unregulated indicator collected informally outside the stock exchanges. It is not published, verified, or endorsed by SEBI, NSE, or BSE, can vary widely between trackers, and is not always accurate. Investors interested in checking informally reported premium levels may refer to independent trackers such as InvestorGain.com or Chittorgarh.com, treating this data as supplementary only.
Conclusion
ABH Healthcare’s initial public offering, marked by strong QIB conviction against more measured retail and NII participation, is set to list on the NSE SME platform tomorrow, September 1, 2026. Investors should track the stock’s opening trade and evaluate the company’s pharmaceutical manufacturing fundamentals for any post-listing investment decisions. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track ABH Healthcare’s listing-day performance.
FAQs on ABH Healthcare Listing
When does ABH Healthcare list on the stock exchange?
Ans. ABH Healthcare shares are scheduled to list on the NSE SME platform tomorrow, September 1, 2026.
What was the ABH Healthcare IPO subscription status?
Ans. ABH Healthcare’s initial public offering saw QIB subscription reach 8.37 times, while individual investors were subscribed 0.93 times and non-institutional investors 0.67 times, as of the close of Day 3 trading.
Why was QIB subscription much higher than retail for ABH Healthcare?
Ans. The QIB category subscription of 8.37 times significantly exceeded retail and NII subscription levels, reflecting stronger institutional confidence relative to individual investor participation in this specific issue.
What does ABH Healthcare manufacture?
Ans. ABH Healthcare manufactures active pharmaceutical ingredients (APIs) and pharma intermediates from its manufacturing base in Ferozepur, Punjab.
When was the ABH Healthcare IPO allotment finalised?
Ans. The basis of allotment for ABH Healthcare was finalised on August 28, 2026, with shares credited to successful applicants’ demat accounts by August 31, 2026.
Should I buy ABH Healthcare shares on listing day?
Ans. Whether to hold or buy on listing day depends on individual risk tolerance and the company’s long-term fundamentals, rather than the subscription figures alone. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decision.
